Chronic Rhinosinusitis with Nasal Polyps: A Survey on Routine Management and Evaluation of Disease Control in Practice.
CRSwNP
biologics
disease control
disease severity
endoscopic sinus surgery
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
26 Oct 2023
26 Oct 2023
Historique:
received:
22
09
2023
revised:
19
10
2023
accepted:
24
10
2023
medline:
25
11
2023
pubmed:
25
11
2023
entrez:
25
11
2023
Statut:
epublish
Résumé
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a disease with a significant impact on quality of life. The overall goal of CRSwNP management, as with other chronic conditions, is to achieve "disease control", and for that reason, a definition of control of disease is pivotal in deciding the best treatment strategy. Although many staging systems have already been developed to evaluate the disease, disease control is not yet to be standardized, and a specific tool that is consistently applied and accepted by all practitioners is still missing in daily clinical practice. To gain an overview of the implementation and limitations of existing guidelines and to shed light on real-life definitions of control and disease severity, we conducted a nationwide survey of otorhinolaryngologists routinely treating CRSwNP to identify unmet clinical needs in Italy. The results showed homogeneous responses regarding the knowledge contained in international guidelines while highlighting the difficulty of their implementation in day-to-day practice. Respondents called attention to the importance of clinical symptoms, giving more weight to the patient's perspective. Among the symptoms to be considered, respondents emphasized nasal obstruction, followed by loss of sense of smell and rhinorrhea. Others also believe that the physician's perspective should be considered, and the inclusion of endoscopy as a measure of control was warranted by many. The need for a specific tool that is able to unequivocally ascertain disease control is increasingly pivotal in this new era of biologics for treating CRSwNP.
Identifiants
pubmed: 38003847
pii: jpm13111531
doi: 10.3390/jpm13111531
pmc: PMC10672031
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Laryngoscope. 2019 Sep;129(9):1969-1975
pubmed: 30720213
Clin Transl Allergy. 2020 Jan 3;10:1
pubmed: 31908763
Curr Opin Otolaryngol Head Neck Surg. 2023 Feb 1;31(1):17-23
pubmed: 36730615
J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):565-72
pubmed: 27393770
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1133-1141
pubmed: 33065369
J Allergy Clin Immunol. 2021 Jan;147(1):29-36
pubmed: 33227318
Rhinology. 2016 Jun;54(2):129-33
pubmed: 27017484
Biomed Res Int. 2015;2015:930756
pubmed: 26167506
Front Allergy. 2023 Apr 21;4:1083964
pubmed: 37152304
Allergy. 2017 Feb;72(2):282-290
pubmed: 27392210
Allergy. 2020 Nov;75(11):2867-2878
pubmed: 32424899
Rhinology. 2023 Jun 1;61(3):194-202
pubmed: 36999780
N Engl J Med. 2019 Jul 4;381(1):55-63
pubmed: 31269366
Acta Otorhinolaryngol Ital. 2022 Feb;42(1):1-16
pubmed: 34297014
Rhinology. 2020 Jun 1;58(3):213-217
pubmed: 32415826
Rhinology. 2020 Feb 20;58(Suppl S29):1-464
pubmed: 32077450
J Otolaryngol Head Neck Surg. 2021 Jun 16;50(1):36
pubmed: 34134762
Acta Otorhinolaryngol Ital. 2023 Apr;43(Suppl. 1):S3-S13
pubmed: 37698095
Rhinology. 2012 Mar;50(1):1-12
pubmed: 22469599
J Pers Med. 2023 Jan 28;13(2):
pubmed: 36836468
Rhinology. 2020 Apr 1;58(2):112-125
pubmed: 32172284
J Pers Med. 2022 May 29;12(6):
pubmed: 35743682
J Pers Med. 2022 May 23;12(5):
pubmed: 35629268
Curr Allergy Asthma Rep. 2017 Apr;17(4):20
pubmed: 28337570
J Pers Med. 2022 Jul 26;12(8):
pubmed: 35893310
Allergy. 2020 Apr;75(4):911-920
pubmed: 31713250
Lancet Respir Med. 2022 Apr;10(4):315-317
pubmed: 35012709
Laryngoscope. 2023 Aug 26;:
pubmed: 37632705
Allergy. 2023 Oct;78(10):2669-2683
pubmed: 37203259
Acta Otorhinolaryngol Ital. 2023 Oct;43(5):324-340
pubmed: 37224173